Pillar Biosciences is a molecular diagnostic company providing decentralized NGS testing solutions to enable highly accurate and accessible cancer care decision support.

Pillar Biosciences empowers oncologists to make data-driven decisions in cancer care, spanning from tumor profiling to therapy selection and ongoing monitoring for recurrence. Pillar's NGS solutions, led by the oncoReveal™ CDx pan-cancer solid tumor IVD, decentralize the testing process and allow clinical laboratories to complete testing in-house, ultimately lowering diagnostic costs while enhancing access and efficiency for clinicians, prescribers, and patients. The company boasts a portfolio of over 20 NGS testing kits available in IVD or RUO formats, with several others in various stages of development, including a comprehensive liquid biopsy assay and a tumor-informed MRD assay.